UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...
Xcorporeal, Inc. (NYSE Amex: XCR) (the “Company” or “Xcorporeal”) announced today that, on August 20, 2009, the Company received...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________...
Xcorporeal, Inc. (NYSE Amex: XCR) (the ?Company? or ?Xcorporeal?) announced today that on May 15, 2009, the Company received...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d...
Xcorporeal, Inc. (NYSE Amex:XCR) announced today that it has filed its Form 10-K with the Securities and Exchange Commission for...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO...
Xcorporeal, Inc. (NYSE Amex:XCR) announced today that, as a result of general economic conditions and a deterioration in its...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.